KRT18 and breast carcinoma: The study performed by Olofsson (2007), which used cytokeratin 18 to monitor the cell death induced by each course of chemotherapy with docetaxel or ECF in 61 breast cancer patients, reported a significant relationship between increased serum M30 level and the pathologic response to these chemotherapies (20).